Logo for Novan Inc

Novan Investor Relations Material

Latest events

Logo for Novan Inc

Q1 2023

Novan
Logo for Novan

Q1 2023

15 May, 2023
Logo for Novan

Q4 2022

30 Mar, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Novan Inc

Access all reports
Novan, Inc., a pre-commercial nitric oxide-based pharmaceutical company, focuses on dermatology and anti-infective therapies. It is engaged in developing nitric oxide-based therapeutics for the treatment of skin pathologies, including acne vulgaris and other inflammatory conditions such as psoriasis, atopic dermatitis, wound healing, endometriosis, hidradenitis suppurativa (HS) and eczema; and microbial infections in dermatology such as MRSA infections. The company's product candidate pipeline consists of two Phase 3 clinical stage candidates: M834 for HS and an acne treatment; as well as a Phase 2 clinical candidate for topical fungal infections.